Dual labeling with 5-aminolevulinic acid and fluorescein in high-grade glioma surgery with a prototype filter system built into a neurosurgical microscope: technical note.
暂无分享,去创建一个
Nils Warneke | Walter Stummer | W. Stummer | M. Schwake | Michael Schwake | Christian Ewelt | N. Warneke | C. Ewelt | Eric Suero Molina | Michael Müther | Stephanie Schipmann | S. Schipmann | M. Müther | E. Suero Molina | Christian Ewelt
[1] David W Roberts,et al. Fluorescein Guidance in Glioblastoma Resection. , 2017, The New England journal of medicine.
[2] Kathleen Seidel,et al. Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-aminolevulinic acid intraoperative fluorescence imaging and brain mapping. , 2012, Neurosurgery.
[3] Brian W Pogue,et al. Review of Neurosurgical Fluorescence Imaging Methodologies , 2010, IEEE Journal of Selected Topics in Quantum Electronics.
[4] W. Stummer,et al. Conscious sedation with dexmedetomidine compared with asleep-awake-asleep craniotomies in glioma surgery: an analysis of 180 patients. , 2018, Journal of neurosurgery.
[5] Z L Gokaslan,et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. , 2001, Journal of neurosurgery.
[6] Xian-Fu Zhang,et al. Fluorescence Properties of Twenty Fluorescein Derivatives: Lifetime, Quantum Yield, Absorption and Emission Spectra , 2014, Journal of Fluorescence.
[7] W. Stummer,et al. Maximizing safe resections: the roles of 5-aminolevulinic acid and intraoperative MR imaging in glioma surgery—review of the literature , 2017, Neurosurgical Review.
[8] Walter Stummer,et al. Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery , 2012, Journal of Neuro-Oncology.
[9] W. Stummer,et al. Fluorescence Imaging/Agents in Tumor Resection. , 2017, Neurosurgery clinics of North America.
[10] C. Wirtz,et al. Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival , 2015, PloS one.
[11] Alexander Brawanski,et al. Sodium fluorescein–guided resection under the YELLOW 560 nm surgical microscope filter in malignant brain tumor surgery—a feasibility study , 2013, Acta Neurochirurgica.
[12] S. Eljamel. 5-ALA Fluorescence Image Guided Resection of Glioblastoma Multiforme: A Meta-Analysis of the Literature , 2015, International journal of molecular sciences.
[13] W. Stummer,et al. In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid. , 1998, Journal of photochemistry and photobiology. B, Biology.
[14] Francesco Acerbi,et al. Fluorescein-guided surgery for grade IV gliomas with a dedicated filter on the surgical microscope: preliminary results in 12 cases , 2013, Acta Neurochirurgica.
[15] M. Kubista,et al. Absorption and fluorescence properties of fluorescein , 1995 .
[16] H Stepp,et al. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. , 2000, Journal of neurosurgery.
[17] M. Berger,et al. Extent of resection influences outcomes for patients with gliomas. , 2011, Revue neurologique.
[18] Oren Sagher,et al. Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival. , 2012, Journal of neurosurgery.
[19] W. Stummer,et al. Kinetics of Photofrin II in perifocal brain edema. , 1993, Neurosurgery.
[20] W. Stummer. Poor man’s fluorescence? , 2015, Acta Neurochirurgica.
[21] H. Reulen,et al. Formation and resolution of human peritumoral brain edema. , 1994, Acta neurochirurgica. Supplementum.
[22] Walter Stummer,et al. Simultaneous fluorescein sodium and 5-ALA in fluorescence-guided glioma surgery , 2015, Acta Neurochirurgica.
[23] J. Rutka,et al. Study of the biodistribution of fluorescein in glioma-infiltrated mouse brain and histopathological correlation of intraoperative findings in high-grade gliomas resected under fluorescein fluorescence guidance. , 2015, Journal of neurosurgery.
[24] K Sartor,et al. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. , 1994, Neurosurgery.
[25] Francesco Acerbi,et al. Is fluorescein-guided technique able to help in resection of high-grade gliomas? , 2014, Neurosurgical focus.
[26] W. Stummer,et al. Randomized, Prospective Double-Blinded Study Comparing 3 Different Doses of 5-Aminolevulinic Acid for Fluorescence-Guided Resections of Malignant Gliomas , 2017, Neurosurgery.
[27] J. Griffiths,et al. Fluorescence-guided surgical sampling of glioblastoma identifies phenotypically distinct tumour-initiating cell populations in the tumour mass and margin , 2012, British Journal of Cancer.
[28] W. Stummer. Factors confounding fluorescein-guided malignant glioma resections: edema bulk flow, dose, timing, and now: imaging hardware? , 2015, Acta Neurochirurgica.
[29] R. Mirimanoff,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[30] W. Stummer,et al. Dual-labeling with 5-aminolevulinic acid and fluorescein for fluorescence-guided resection of high-grade gliomas: technical note. , 2017, Journal of neurosurgery.
[31] Henry Brem,et al. Independent association of extent of resection with survival in patients with malignant brain astrocytoma. , 2009, Journal of neurosurgery.
[32] Laurent Mahieu-Williame,et al. Two-peaked 5-ALA-induced PpIX fluorescence emission spectrum distinguishes glioblastomas from low grade gliomas and infiltrative component of glioblastomas , 2013, Biomedical optics express.
[33] G. Reifenberger,et al. Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[34] F. Floeth,et al. The value of metabolic imaging in diagnosis and resection of cerebral gliomas , 2005, Nature Clinical Practice Neurology.
[35] J. Uhm,et al. Overall survival in patients with glioblastoma before and after bevacizumab approval , 2018, Current Medical Research and Opinion.
[36] F. Zanella,et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.
[37] Walter Stummer,et al. Where and When to Cut? Fluorescein Guidance for Brain Stem and Spinal Cord Tumor Surgery—Technical Note , 2017, Operative neurosurgery.
[38] P. Ferroli,et al. What is the best timing for fluorescein injection during surgical removal of high-grade gliomas? , 2015, Acta Neurochirurgica.
[39] Binsheng Zhao,et al. Aggressive resection at the infiltrative margins of glioblastoma facilitated by intraoperative fluorescein guidance. , 2017, Journal of neurosurgery.
[40] Herbert Stepp,et al. 5-Aminolevulinic Acid-derived Tumor Fluorescence: The Diagnostic Accuracy of Visible Fluorescence Qualities as Corroborated by Spectrometry and Histology and Postoperative Imaging , 2013, Neurosurgery.
[41] Answer to: “Sodium fluorescein-guided resection under the YELLOW 560-nm surgical microscope filter in malignant brain tumor surgery—a feasibility study” (April 2013, Volume 155, Issue 4, pp 693–69) , 2013, Acta Neurochirurgica.
[42] H Stepp,et al. Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. , 1998, Neurosurgery.